Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FIIT-NS
- Development stage
- Preclinical
- Lead developer
- Fytexia
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
FIIT-NS is a proprietary dietary supplement composed of a combination of plant extracts (grapefruit, grape, green tea, guarana, black carrot) and vitamin B3 (niacin). It is designed to support healthy metabolic aging by improving metabolic markers such as lipid profile, glycemic control, oxidative status, and inflammation. Clinical studies in overweight and obese adults have shown that daily supplementation with 900 mg of FIIT-NS can reduce abdominal fat mass and waist circumference while improving health-related quality of life measures including vitality and physical functioning. The product’s mechanism involves the synergistic action of polyphenols (antioxidants), caffeine (from guarana/green tea), and vitamin B3 to enhance energy metabolism and reduce fatigue. Developed by Fytexia, it is marketed for use in tablets, capsules, sachets/stick-packs or functional beverages[1][4][5][6][9].
- Brand names
- FIIT-NS
- Other names
- Fiit-nsFiit-ns®
02
Targets
ADORA2A (Adenosine A₂A Receptor)HCAR2 (Hydroxycarboxylic acid receptor 2)ADORA1 (Adenosine receptor A1 subtype)
Beyond the preview
Go deeper on FIIT-NS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FIIT-NS.